Results 241 to 250 of about 526,880 (329)

Risk Factors for Readmission Following Minimally Invasive Hysterectomy for Benign Indications in the United States—Outpatient and Inpatient Setting

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Raanan Meyer, Susie Lau, Shannon Salvador, Yosef Nasseri, Moshe Barnajian, Gabriel Levin   +5 more
wiley   +1 more source

Performance of swallowing function between older people with and without clinical complaints. [PDF]

Codas
Araújo RCP, Godoy CMA, Ferreira LMBM, Godoy JF, Magalhães H.   +4 more
europepmc   +1 more source

Placenta accreta spectrum and uterine SCAR dehiscence: Distinct entities or a continuum? An expert debate and call for standardization

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
This review explores the ongoing debate on whether placenta accreta spectrum and uterine scar dehiscence are distinct entities or part of a continuum. It discusses diagnostic challenges, surgical implications, and clinical consequences, emphasizing how misclassification may affect counseling, operative strategy, and outcomes, and calling for clearer ...
Theophilus Adu‐Bredu, Rozi Aditya Aryananda, Sarah P. Walker, Yaw Gyanteh Owusu, Thorsten Braun, Hooman Soleymani majd, Pedro Viana Pinto, Olivier Morel, Abdalla Mousa, Helena C. Bartels, Ammar Al Naimi, Maddalena Morlando, Karin A. Fox, Sally L. Collins   +13 more
wiley   +1 more source

Effectiveness of orofacial myofunctional intervention to mitigate facial aging signs: a clinical trial. [PDF]

Codas
Frazão YS, Manzi SB, Krakauer L, Berretin-Felix G.   +3 more
europepmc   +1 more source

Optimizing Prolonged (6 h) Normothermic Machine Perfusion of Donor Kidneys (PROPER Study)

Artificial Organs, EarlyView.
Prolonged ex situ normothermic machine perfusion of donor kidneys up to 6 h is feasible, maintaining viability and histological integrity. Key protocol optimizations include fresh red blood cells, albumin supplementation, and urine recirculation—laying the groundwork for assessment and potential pretransplant interventions in future clinical trials ...
Asel S. Arykbaeva, Veerle A. Lantinga, L. Leonie van Leeuwen, Marten Engelse, Ton J. Rabelink, Jesper Kers, Jason B. Doppenberg, Volkert A. L. Huurman, Robert A. Pol, Robert C. Minnee, Henri G. D. Leuvenink, Rutger J. Ploeg, Cyril Moers, Dorottya K. de Vries, Ian P. J. Alwayn   +14 more
wiley   +1 more source

Internal jugular phlebectasia: case report and literature review. [PDF]

J Vasc Bras
Pacheco LS, Manhanelli MAB, Costa JA.
europepmc   +1 more source

Sinais distintivos

Revista de Direito Comercial, 2020
openaire   +2 more sources

A Population‐Based Matched Cohort Study of Extra‐Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease

Alimentary Pharmacology &Therapeutics, EarlyView.
This illustration summarises our primary findings highlighting the rising incidence of certain extra‐digestive cancers among persons with IBD over the 25‐year study duration (left), and the relative rates of extra‐digestive cancer incidence and mortality among persons with IBD in recent years (2010–2019) compared to their age‐ and sex‐matched controls (
Sanjay K. Murthy, Faria Ahmed, Michael Pugliese, Monica Taljaard, Parul Tandon, Priscilla Matthews, Gilaad G. Kaplan, Stephanie Coward, Charles N. Bernstein, Eric I. Benchimol, M. Ellen Kuenzig, Laura E. Targownik, Harminder Singh, on behalf of the Canadian Gastro‐Intestinal Epidemiology Consortium (CanGIEC)   +13 more
wiley   +1 more source

Community health workers' knowledge, attitudes and practices in the detection of respiratory symptomatic patients. [PDF]

Rev Bras Enferm
Ribeiro AFO, Nogueira LMV, Andrade EGR, Rodrigues ILA, Lima IB, Duarte BAS.   +5 more
europepmc   +1 more source

Safety of Immune Checkpoint Inhibitors Prior to Liver Transplantation in Hepatocellular Carcinoma

Alimentary Pharmacology &Therapeutics, EarlyView.
Patients who received immune checkpoint inhibitors before liver transplant for the treatment of hepatocellular carcinoma had rejection and survival outcomes comparable to those without ICI exposure. Most rejection episodes were effectively managed with medical therapy.
L. Aceituno, C. Magyar, P. Tabrizian, R. Marino, K. Watt, D. Chascsa, G. Schnickel, V. Banz, F. Alconchel, Celia Martagon, C. Moctezuma, T. Baker, C. Nwaduru, F. J. Krendl, R. Oberhuber, L. Ruiz‐Ortega, C. Demers, R. Bucur, G. O'Kane, A. Vogel, B. Mínguez, G. Sapisochin   +21 more
wiley   +1 more source